Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioAmber Inc. BIOAQ

BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints, food additives and personal care products. BioAmber produces bio-succinic acid at a facility in Sarnia, On


OTCPK:BIOAQ - Post by User

Comment by Breakingbad2017on Feb 14, 2018 6:11pm
102 Views
Post# 27561466

RE:A fund just bought over 5% of the company

RE:A fund just bought over 5% of the company
bobyback wrote:
According to the filling "Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions"

Link you MF. The filling has zero ownership
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) BioAmber Inc. (Name of Issuer) Common (Title of Class of Securities) 09072Q106 (CUSIP Number) December 31, 2017 Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is filed: X	Rule 13d-1(b) ?	Rule 13d-1(c) ?	Rule 13d-1(d) The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 09072Q106 1 Name of reporting person S.S. or I.R.S. Identification No. of Above Person CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 2 Check the appropriate box if a member of a group (a) (b) ? 3 SEC USE ONLY 4 Citizenship or place of organization Vancouver, British Columbia, Canada 5 Sole Voting Power Number of Shares 0 Beneficially 6 Shared Voting Power owned by each reporting 7 Sole Dispositive Power person with 0 8 Shared Dispositive Power 9 Aggregate amount beneficially owned by each reporting person Connor, Clark & Lunn Investment Management Ltd. 0 10 Check box if the aggregate amount in row (9) excludes certain shares* Not Applicable 11 Percent of Class Represented by amount in Row 9 Connor, Clark & Lunn Investment Management Ltd. 0.0% 12 Type of Reporting* IA (Investment Adviser) SCHEDULE 13G Item 1. 	 (a)	BioAmber Inc. 	 (b)	1250 Rene Levesque West, Suite 4310 Montreal, Quebec H3B 4W8 Canada Item 2. 	(a)	CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 	(b)	2300-1111 West Georgia Street 		Vancouver, BC, 		V6E 4M3 		Canada 	(c)	Vancouver, British Columbia, Canada 	(d)	Common 	(e)	09072Q106 Item 3.	If this statement is filed pursuant to Rule 13d-1(b), 	or 13d-2(h), check whether the person filing is a: 	Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E)  Item 4.	Ownership (a)	 0 	(b)	0 	(c)	 		(i)	0 		(ii)	0 		(iii)	0 		(iv)	0 Item 5.	Ownership of Five Percent or Less of a Class 	Yes Item 6.	Ownership of More than Five Percent on Behalf of Another Person 	Not applicable Item 7.	Identification and Classification of the Subsidiary Which Acquired the 	Security being Reported on By the Parent Holding Company 	Not applicable 	 Item 8.	Identification and Classification of Members of the Group 	Not applicable Item 9.	Notice of Dissolution of Group 	Not applicable Item 10.	Certification 	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. 	Connor, Clark & Lunn Investment Management Ltd. ("Company") 	is of the view that it and the investment companies and other 	accounts that it manages are not acting as a "group" for the 	purposes of section 13(d) under the Act and that it and such 	investment companies and accounts are not otherwise required 	to attribute to each other the "beneficial ownership" of securities 	"beneficially owned" under Rule 13D-3 promulgated under the 	1934 Act. Therefore, it is of the view that the shares held 	by the Company and such investment companies and accounts should 	 not be aggregated for purposes of section 13(d). 	After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 7, 2018 _ 										Date _____________________________ 										Signature Phil Cotterill, Director _ 										Name/Title 3 		Page
<< Previous
Bullboard Posts
Next >>